ArticleResearch square2024

The CLCF1-CNTFR axis drives an immunosuppressive tumor microenvironment and blockade enhances the effects of established cancer therapies.

Eric Sweet-Cordero et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.